Skip to content

Speaking

Upcoming Talks

To be presented at the 2019 Supreme Court of Ohio Specialized Dockets Conference at The Ohio Union, Columbus, Ohio on November 22, 2019

Real Medicines Have Real Risks: An Explanation of Marijuana’s Potential Health Hazards

Summary:

Any substance strong enough to affect disease processes is strong enough to also have potentially severe side effects.

A curious feature of the modern medical marijuana movement is its inattention to potential risks. For example, Ohio’s medical marijuana program website informs the public (on 30 May 2019) that cannabis can treat 21 different diseases — yet says nothing about possible risks.

This presentation will describe the biochemical actions of cannabis and how those actions contribute to its known risks. Anyone who consumes cannabis, or who works with cannabis-consuming individuals, will benefit from understanding its possible adverse effects.

Notable Past Appearances

2019 Healthcare Ethics and Law Conference at Samford University, Birmingham, Alabama on September 6, 2019

Real Medicines Have Real Risks: An Explanation of Marijuana’s Potential Health Hazards

Northwest Ohio Psychiatric Physicians Association meeting, February 13, 2019

Addressing Negative and Cognitive Symptoms in Schizophrenia

FaceBook Psychiatry Network, December 12, 2018

Journal Club Discussant: Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis

Supreme Court of Ohio Specialized Dockets Conference. October 11, 2018

Psychosis 101

NEOMED Research Forum, Tuesday May 8th, 2018.

What Can Niacin Teach Us About Schizophrenia

Grand rounds presentation to the Summa Health System and to the Cleveland Clinic-Akron General Hospital.

Listening to Clozapine: The Case for Many, Physiologically-Distinct Schizophrenias

Public lecture for mental health awareness. Cincinnati, Ohio

Psychosis: Origin, Occurrence, Treatment

Public lecture for mental health awareness. Cincinnati, Ohio

Diet and Mental Health

Biomarkers in Psychiatry Course, Neuroscience School of Advanced Studies. Bressanone, Italy

Niacin Subsensitivity as a Schizophrenia Biomarker

Annual Psychiatric Update meeting of the Ohio Psychiatric Physicians Association, March 31, 2019.

First Episode Psychosis: New findings challenge old assumptions.

FaceBook Psychiatry Network, December 19, 2018

Journal Club Discussant: Schizophrenia: an integrated sociodevelopmental-cognitive model

Heartland Behavioral Healthcare Hospital, November 9, 2018

Assessment and response to agitation, aggression, and violent behavior

Cuyahoga County Stepping Up Summit, October 18, 2018

Opportunity or Peril: Schizophrenia Treatment in Jail

Statewide meeting of NAMI Ohio, Friday May 4th, 2018.

Best Practices, Best Outcomes: How to maximize recovery in the schizophrenia-spectrum illnesses.

Presented at the Ohio Attorney General’s Task Force on Criminal Justice and Mental Illness. Columbus, Ohio. Video Recording

The Schizophrenia Opportunity

Grand rounds presentation to the University of Cincinnati Lindner Center of HOPE

Antidepressant Actions of Acetyl-L-Carnitine: An over-the-counter supplement with well-documented psychotropic effects

Hui Long Guan Academic Medical Center. Beijing, China

The Historical Development of the Schizophrenia Concept and the Niacin Skin Flush as a Schizophrenia Subtype

Grand rounds presentation to the Oregon Health & Science University

Allopurinol (yes, the ‘gout medicine’) as a possible therapy for schizophrenia